Mkts

Prothena Corporation plc

NASDAQ: PRTA
$8.23-0.50 (-5.73%)
As of Nov 12, 4:00 PM ET

Key statistics

Day range
8.218.70
52-week range
7.7311.80
Today
Open8.70
Previous close8.23
Volume931.6K
Valuation
Market cap448.28M
P/E ratio—
EPS (TTM)-0.83
Income & risk
Dividend / yield—
Beta-0.24
Avg volume489.3K
Discussion

PRTA News

Stories mentioning PRTA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue51,08421.002,4154,4202,8282,123970.00132,014
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development12,62714,58628,93840,51750,81150,17250,72357,510
Sales General & Admin
Total Operating Expenses21,04924,22442,65589,03668,40967,02067,48373,637
Operating Income (Loss)30,035(24,203)(40,240)(84,616)(65,581)(64,897)(66,513)58,377
Interest Income
Interest Expense
Other Expense271.00(22.00)(23.00)(143.00)(140.00)9.00(66.00)(51.00)
Pretax Income32,722(21,579)(36,912)(80,965)(61,373)(59,501)(59,836)64,847
Tax Provision1.0010.00(371.00)44,802(1,178)(1,545)(835.00)(2,039)
Net Income (Loss)32,721(21,589)(36,541)(125,767)(60,195)(57,956)(59,001)66,886
Earnings Per Share (Basic)0.61(0.40)(0.68)(2.34)(1.12)(1.08)(1.10)1.24
Earnings Per Share (Diluted)0.60(0.40)(0.68)(2.34)(1.12)(1.08)(1.10)1.22
Weighted Average Shares Outstanding (Basic)53,70853,82953,83053,82753,82753,77253,79053,767
Weighted Average Shares Outstanding (Diluted)54,10953,82953,83053,82753,82753,77253,79055,043

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PRTA

Prothena Corporation plc (NASDAQ: PRTA) is a stock listed on the Nasdaq Stock Market under the ticker symbol PRTA. It last traded at $8.23 (Nov 12, 2026, 4:00 PM ET), down 5.7% on the day. That gives Prothena a market capitalisation of $448.3M.

Over the past 52 weeks PRTA has traded between $7.73 and $11.80.

Revenue for the quarter ended Mar 31, 2026 was $51.1M; net income $32.7M. Revenue was up 1706% from $2.8M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$51.1M$32.7M64.1%
Dec 31, 2025$21.0K-$21.6M-102804.8%
Sep 30, 2025$2.4M-$36.5M-1513.1%
Jun 30, 2025$4.4M-$125.8M-2845.4%

From Prothena’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…